NEW YORK, NY--(Marketwire - 06/02/11) - United Health Products, Inc. (OTCQB: UEEC) (Pinksheets:UEEC - News), which develops and markets products and technologies in the healthcare sector, today announced it has elected new members to its Board of Directors. The new members include: Sherman Lazrus -- former Deputy Assistant Secretary of Defense; Dr. John Capotorto and Dr. Rodney Leibowitz. Continuing to serve on the Board are Dr. Phillip Forman, Chairman and Chief Executive Officer; Jan E. Chason who also serves Chief Financial Officer and Michael Wiechnik and Richard P. Rifenburgh.Sherman Lazrus is President and Chief Executive Officer of American Medical Capital, a division of American Medical Enterprises, LLC, a financial services and investment banking company. Mr. Lazrus was initially employed with the Federal Government and while at the Department of Health, Education and Welfare he was involved with the development of the Medicare and Medicaid programs and later served as the Director of Policy Coordination for the two programs. Mr. Lazrus is affectionately known as the Father of Medicare and Medicaid. . Mr. Lazrus also served in the office of the Director of the National Institutes of Health and was involved in planning activities in areas involving biomedical research. Mr. Lazrus later administered the Social Security Administration's Disability Insurance Research Programs as Director of Program Analysis. Mr. Lazrus' final Federal Government position encompassed the administration of the military healthcare system. In serving as the Deputy Assistant Secretary of Defense, he was the Federal Government's senior career health official. Mr. Lazrus has also been involved as a board member of several public healthcare related companies. He served as Chairman of the Board of Emergency Filtration Products (EMFP) and as a board member of Imaging Diagnostic Systems, Inc. (IMDS) and Diasys Corporation (DYXC).John V. Capotorto, MD, MBA is the Chief Medical Officer and Compliance Director for The Center for Wound Healing, Inc, and the President of the American Association of Wound Care Management. Dr. Capotorto has been an attending physician in Adult and Pediatric Endocrinology and clinical assistant professor at State University of New York Health Science Center at Brooklyn. His board certifications have included Internal Medicine, Pediatrics, Adult and Pediatric Endocrinology and Metabolism and is accredited in hyperbaric medicine. Additionally, he has been the Medical Director of the Diabetes Treatment Center at Staten Island University Hospital and has extensive experience in both wound care and hyperbaric medicine.Dr. Rodney P. Leibowitz was a founding member in the formation of the U.S. Department of Homeland Security and is an Honorary Police Surgeon for the NYS and NYC Police Departments and NYC Fire Department. He is an active member of National Disaster Medical Service, a branch of the US Department of Health and Human Services. Dr. Leibowitz has maintained a full dental practice for 35 years and is a Consulting Doctor for the Office of Professional Discipline for the State of New York and, in addition, was an Attending Doctor at Maimonides Medical Center.Dr. Phillip Forman, Chairman and CEO, stated, "We have a Board of Directors that will both serve our shareholders and address the needs of our products and market. We are excited to have a former senior US Government health official as a member. Along with me, we have two additional doctors that are very knowledgeable and accredited. They have served in various government agencies and companies involved in wound care management and have won various awards and honors. We have now assembled a leading Board of Directors to assist the company in its future growth and development.About United Health Products, Inc.United Health Products, Inc. (UEEC) develops, manufactures and markets products and technologies in the healthcare sector. UEEC's principal operating subsidiary is Epic Wound Care, Inc. which produces hemostatic gauze, derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds. The Company is focused on identifying emerging healthcare products and technologies for strategic partnership or acquisition.Safe Harbor StatementSafe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.